These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

390 related articles for article (PubMed ID: 26307094)

  • 1. High-resolution mass spectrometry glycoprofiling of intact transferrin for diagnosis and subtype identification in the congenital disorders of glycosylation.
    van Scherpenzeel M; Steenbergen G; Morava E; Wevers RA; Lefeber DJ
    Transl Res; 2015 Dec; 166(6):639-649.e1. PubMed ID: 26307094
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plasma N-glycan profiling by mass spectrometry for congenital disorders of glycosylation type II.
    Guillard M; Morava E; van Delft FL; Hague R; Körner C; Adamowicz M; Wevers RA; Lefeber DJ
    Clin Chem; 2011 Apr; 57(4):593-602. PubMed ID: 21273509
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A new strategy implementing mass spectrometry in the diagnosis of congenital disorders of N-glycosylation (CDG).
    Casetta B; Malvagia S; Funghini S; Martinelli D; Dionisi-Vici C; Barone R; Fiumara A; Donati MA; Guerrini R; la Marca G
    Clin Chem Lab Med; 2020 Aug; 59(1):165-171. PubMed ID: 32776892
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A new method for the rapid diagnosis of protein N-linked congenital disorders of glycosylation.
    Heywood WE; Mills P; Grunewald S; Worthington V; Jaeken J; Carreno G; Lemonde H; Clayton PT; Mills K
    J Proteome Res; 2013 Jul; 12(7):3471-9. PubMed ID: 23742123
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Laboratory diagnosis of congenital disorders of glycosylation type I by analysis of transferrin glycoforms.
    Babovic-Vuksanovic D; O'Brien JF
    Mol Diagn Ther; 2007; 11(5):303-11. PubMed ID: 17963418
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intact transferrin and total plasma glycoprofiling for diagnosis and therapy monitoring in phosphoglucomutase-I deficiency.
    Abu Bakar N; Voermans NC; Marquardt T; Thiel C; Janssen MCH; Hansikova H; Crushell E; Sykut-Cegielska J; Bowling F; MØrkrid L; Vissing J; Morava E; van Scherpenzeel M; Lefeber DJ
    Transl Res; 2018 Sep; 199():62-76. PubMed ID: 30048639
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mass spectrometry of transferrin and apolipoprotein C-III for diagnosis and screening of congenital disorder of glycosylation.
    Wada Y
    Glycoconj J; 2016 Jun; 33(3):297-307. PubMed ID: 26873821
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The impact of mass spectrometry in the diagnosis of congenital disorders of glycosylation.
    Sturiale L; Barone R; Garozzo D
    J Inherit Metab Dis; 2011 Aug; 34(4):891-9. PubMed ID: 21384227
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum N-glycan and O-glycan analysis by mass spectrometry for diagnosis of congenital disorders of glycosylation.
    Xia B; Zhang W; Li X; Jiang R; Harper T; Liu R; Cummings RD; He M
    Anal Biochem; 2013 Nov; 442(2):178-85. PubMed ID: 23928051
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Screening for abnormal glycosylation in a cohort of adult liver disease patients.
    Jansen JC; van Hoek B; Metselaar HJ; van den Berg AP; Zijlstra F; Huijben K; van Scherpenzeel M; Drenth JPH; Lefeber DJ
    J Inherit Metab Dis; 2020 Nov; 43(6):1310-1320. PubMed ID: 32557671
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phenotypic and genotypic spectrum of congenital disorders of glycosylation type I and type II.
    Al Teneiji A; Bruun TU; Sidky S; Cordeiro D; Cohn RD; Mendoza-Londono R; Moharir M; Raiman J; Siriwardena K; Kyriakopoulou L; Mercimek-Mahmutoglu S
    Mol Genet Metab; 2017 Mar; 120(3):235-242. PubMed ID: 28122681
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mass spectrometry for congenital disorders of glycosylation, CDG.
    Wada Y
    J Chromatogr B Analyt Technol Biomed Life Sci; 2006 Jun; 838(1):3-8. PubMed ID: 16517226
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum transferrin carrying the xeno-tetrasaccharide NeuAc-Gal-GlcNAc2 is a biomarker of ALG1-CDG.
    Bengtson P; Ng BG; Jaeken J; Matthijs G; Freeze HH; Eklund EA
    J Inherit Metab Dis; 2016 Jan; 39(1):107-14. PubMed ID: 26335155
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transferrin variants: pitfalls in the diagnostics of Congenital disorders of glycosylation.
    Zühlsdorf A; Park JH; Wada Y; Rust S; Reunert J; DuChesne I; Grüneberg M; Marquardt T
    Clin Biochem; 2015 Jan; 48(1-2):11-3. PubMed ID: 25305627
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diagnosis of congenital disorders of glycosylation type-I using protein chip technology.
    Mills K; Mills P; Jackson M; Worthington V; Beesley C; Mann A; Clayton P; Grunewald S; Keir G; Young L; Langridge J; Mian N; Winchester B
    Proteomics; 2006 Apr; 6(7):2295-304. PubMed ID: 16552784
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synergistic use of glycomics and single-molecule molecular inversion probes for identification of congenital disorders of glycosylation type-1.
    Abu Bakar N; Ashikov A; Brum JM; Smeets R; Kersten M; Huijben K; Keng WT; Speck-Martins CE; de Carvalho DR; de Rizzo IMPO; de Mello WD; Heiner-Fokkema R; Gorman K; Grunewald S; Michelakakis H; Moraitou M; Martinelli D; van Scherpenzeel M; Janssen M; de Boer L; van den Heuvel LP; Thiel C; Lefeber DJ
    J Inherit Metab Dis; 2022 Jul; 45(4):769-781. PubMed ID: 35279850
    [TBL] [Abstract][Full Text] [Related]  

  • 17.
    Kodríková R; Pakanová Z; Krchňák M; Šedivá M; Šesták S; Květoň F; Beke G; Šalingová A; Skalická K; Brennerová K; Jančová E; Baráth P; Mucha J; Nemčovič M
    Biomedicines; 2023 Feb; 11(2):. PubMed ID: 36831116
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Matrix-Assisted Laser Desorption/Ionization Mass Spectrometry to Detect Diagnostic Glycopeptide Markers of Congenital Disorders of Glycosylation.
    Wada Y
    Mass Spectrom (Tokyo); 2020; 9(1):A0084. PubMed ID: 32547898
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of Endoglycosidase H as a diagnostic tool for MAN1B1-CDG patients.
    Duvet S; Mouajjah D; Péanne R; Matthijs G; Raymond K; Jaeken J; Morava E; Foulquier F
    Electrophoresis; 2018 Dec; 39(24):3133-3141. PubMed ID: 29947113
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 20.